Investors

Overview
Havn Life is focused on the rapidly growing field of psychedelic medicine. We have the opportunity to lead the standardization of psychedelic supply to shift human performance & mental health paradigms.
- DEFINED ROUTE TO NATURAL HEALTH PRODUCTS MARKET.
- PRODUCT FORMULATION OF EFFECTIVE MICRODOSING OF NOVEL PSYCHOACTIVE COMPOUNDS.
- MANAGEMENT TEAM WITH EXTENSIVE CLINICAL & NHP PRODUCT DEVELOPMENT EXPERIENCE.
- DEVELOPING STATE-OF-THE-ART MYCOLOGY LAB FOR PSYCHEDELIC EXTRACTION.
- PARTNERSHIP WITH CANADIAN VETERANS FOR PHASE 1 PRE-CLINICAL RESEARCH.
- RECEIVED FIRST HEALTH CANADA LICENSE IN 2020.

Our Team
Collaboration across disciplines
Creating positive patient experiences and mental health outcomes

Dr. Ivan Casselman
Director
Executive-level cannabis advisory. Formerly on the management team of NextLeaf during IPO Extensive nutraceutical formulation, with products available in legal cannabis markets in North America. Research spanning human use of psychedelics (ethnobotany and ethnopharmacy) to the study of plant genetics and analytical chemistry.

Alexzander Samuelsson
Director
Lead chemist of a publicly traded extraction company. Developed intellectual property and patented methods in the extraction of cannabis oils. Strategic support for startups in their implementation of capital projects in Canada, Europe, Central and South Asia through his consulting company Development Catalyst.

Consultants
Legal Counsel
DLA Piper LLP
dlapiper.com
Auditor
De Visser Gray LLP
devissergray.com
Transfer Agent
Odyssey Trust Company
odysseytrust.com

LATEST NEWS
CORPORATE PRESENTATION
